Chemoinformaics analysis of (3E)-3-BUTYLIDENE-4,5-DIHYDRO-2-BENZOFURAN-1-ONE
| Molecular Weight | 190.242 | nRot | 2 |
| Heavy Atom Molecular Weight | 176.13 | nRig | 0 |
| Exact Molecular Weight | 190.099 | nRing | 2 |
| Solubility: LogS | -7.057 | nHRing | 1 |
| Solubility: LogP | 8.787 | No. of Aliphatic Rings | 2 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 1 |
| Atoms Count | 28 | No. of Aliphatic Hetero Cycles | 1 |
| No. of Heavy Atom | 14 | No. of Aromatic Carbocycles | 0 |
| nHetero | 2 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 14 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 12 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 2 | No. of Arom Bond | 0 |
| nHA | 2 | APOL | 30.9791 |
| nHD | 0 | BPOL | 16.6489 |
| QED | 0.241 |
| Synth | 1.557 |
| Natural Product Likeliness | -0.016 |
| NR-PPAR-gamma | 0.04 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Rejected |
| Golden Triangle | Accepted |
| Pgp-inh | 0.001 |
| Pgp-sub | 0 |
| HIA | 0.001 |
| CACO-2 | -4.846 |
| MDCK | 0.0000114 |
| BBB | 0.03 |
| PPB | 0.97779 |
| VDSS | 2.782 |
| FU | 0.0160321 |
| CYP1A2-inh | 0.142 |
| CYP1A2-sub | 0.18 |
| CYP2c19-inh | 0.32 |
| CYP2c19-sub | 0.062 |
| CYP2c9-inh | 0.094 |
| CYP2c9-sub | 0.815 |
| CYP2d6-inh | 0.107 |
| CYP2d6-sub | 0.025 |
| CYP3a4-inh | 0.2 |
| CYP3a4-sub | 0.031 |
| CL | 6.012 |
| T12 | 0.053 |
| hERG | 0.428 |
| Ames | 0.004 |
| ROA | 0.025 |
| SkinSen | 0.96 |
| Carcinogencity | 0.034 |
| EI | 0.918 |
| Respiratory | 0.475 |
| NR-Aromatase | 0.203 |
| Antiviral | No |
| Prediction | 0.62852 |